W. Lee et al. / Tetrahedron 69 (2013) 9175e9182
9181
according to the same synthetic procedure as 2, using 5 instead of
4,7-dibromobenzo[c][1,2,5]thiadiazole and instead of 2-(3-
compound was prepared according to the same synthetic pro-
cedure as H11, using 12 instead of 10. The product was obtained as
an orange solid (80 mg, 77%). Mp 299e302 ꢂC; 1H NMR (300 MHz,
9
hexylthiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. The
product was obtained as a dark red solid (124 mg, 42%). Mp
DMSO-d6):
d
(ppm) 8.77 (s, 2H), 8.12 (s, 1H), 8.02e8.05 (d, J¼8 Hz,
252e254 ꢂC; 1H NMR (300 MHz, CDCl3):
d
(ppm) 10.00 (s, 1H), 8.46
2H), 7.81e7.87 (m, 8H), 7.68e7.76 (m, 8H), 7.53e7.56 (d, J¼8.56 Hz,
6H), 7.30e7.35 (t, J¼7.8 Hz, 8H), 7.24e7.26 (d, J¼6.5 Hz, 2H),
6.96e7.10 (m, 18H), 2.63e2.73 (m, 4H), 1.49e1.65 (m, 4H), 1.11e1.15
(s, 3H), 8.26 (s, 2H), 7.98e8.05 (m, 6H), 7.88 (s, 2H), 7.65e7.70 (d,
J¼1.4 Hz, 5H), 7.59e7.62 (d, J¼1.1 Hz, 5H), 7.43e7.60 (d, J¼0.8 Hz,
6H), 7.06e7.16 (m, 27H); 13C NMR (75 MHz, CDCl3):
d
(ppm) 183.0,
(m, 12H), 0.72e0.76 (m, 6H); 13C NMR (150 MHz, CDCl3):
d (ppm)
152.3, 147.6, 147.3, 140.5, 136.1, 133.3, 131.6, 129.6, 129.3, 127.9, 127.4,
127.3, 127.2, 126.8, 126.7, 124.9, 124.7, 124.5, 124.2, 123.6, 123.0,
118.6, 110.2; MALDI-TOF MS, m/z: calcd for C85H57N5OS3: 1259.373,
found: 1259.394 [M]þ.
153.7,147.5,147.2,143.8,143.3,140.4,136.8,135.9,133.0,131.6,129.7,
129.3,127.7,127.4,126.8,126.3,125.1,124.5,124.1,123.6,123.0,118.4,
115.2, 113.8, 110.0, 31.6, 31.4, 29.9, 29.3, 22.6, 14.1; HRMS, m/z: calcd
for C100H82N6O2S3: 1494.5664, found: 1494.5661.
4.2.12. 5-(7-(5-(4-(3,6-Bis(4-(4-(diphenylamino)styryl)phenyl)-9H-
carbazol-9-yl)phenyl)-3-hexylthiophen-2-yl)benzo[c][1,2,5]thiadia-
zol-4-yl)-4-hexylthiophene-2-carbaldehyde (12). This compound
was prepared according to the same synthetic procedure as 2, using
6 instead of 4,7-dibromobenzo[c][1,2,5]thiadiazole and 9 instead of
2-(3-hexylthiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane.
The product was obtained as an orange solid (70 mg, 52%). Mp
4.3. Device fabrication
Fluorine-doped tin oxide (FTO) glass plates (Pilkington, 8
U ,
sqꢀ1
2.3 mm thick) were cleaned in a detergent solution in an ultrasonic
bath for 15 min, and then rinsed with water and EtOH. The washed
FTO glass plates were immersed in aqueous 10 mM TiCl4 at 70 ꢂC for
30 min. A transparent nanocrystalline layer was deposited on the
FTO glass by the doctor blade printing method using TiO2 paste
(Solaronix, TieNanoxide T/SP, and ENB Korea, TTP-20N) and
a scattering layer paste (Dyesol Timo,18NR-AO, Batch 314). The TiO2
layer was gradually sintered according to a programmed procedure.
The sintered layers (0.2 cm2) consisted of a transparent layer
197e199 ꢂC; 1H NMR (300 MHz, CDCl3):
d (ppm) 9.99 (s, 1H),
7.94e7.97 (d, J¼8.2 Hz, 2H), 7.74e7.78 (m, 8H), 7.63e7.70 (m, 8H),
7.55e7.58 (d, J¼8.6 Hz, 2H), 7.44e7.48 (m, 4H), 7.30e7.32 (m, 4H),
6.99e7.19 (m, 24H), 2.69e2.81 (m, 4H), 1.63e1.78 (m, 4H),
1.25e1.28 (m, 12H), 0.86e0.90 (m, 6H); 13C NMR (75 MHz, CDCl3):
d
(ppm) 183.0, 153.6, 147.6, 147.3, 143.2, 140.6, 137.8, 136.1, 133.3,
(12 mm thick) and a scattering layer (10 mm thick). The TiO2 elec-
131.6, 130.4, 129.3, 127.9, 127.4, 127.2, 126.9, 126.7, 126.1, 125.6,
124.5, 124.2, 123.7, 123.0, 118.6, 110.3, 31.6, 31.5, 30.7, 30.4, 29.7,
29.4, 29.2, 29.0, 22.6, 22.5, 14.1; MALDI-TOF MS, m/z: calcd for
C97H81N5OS3: 1427.560, found: 1427.679 [M]þ.
trodes were again treated with 10 mM TiCl4 at 70 ꢂC for 30 min and
sintered at 450 ꢂC. Subsequently, the TiO2 electrodes were im-
mersed in solutions of the dyes (0.3 mM in THF/EtOH (2:1)) at 50 ꢂC
for 8 h in the dark. The FTO plates for the counter electrodes were
cleaned in a detergent solution in an ultrasonic bath for 15 min.
Then, the counter electrodes were prepared by coating each FTO
plate with a drop of H2PtCl6 solution (2 mg Pt in 1 mL EtOH) and
heating the plate to 450 ꢂC, causing the dyes adsorbed on the TiO2
electrode to adhere to the counter electrode by coverage with a hot-
melt polymer film (Solaronix, Meltonix 1170-60). A drop of elec-
trolyte solution was injected through a hole in the counter elec-
trode and driven into the cell. Finally, the hole was sealed using the
hot-melt polymer film and a cover glass (0.1 mm thick).
4.2.13. (E)-3-(5-(7-(5-(3,6-Bis(4-(4-(diphenylamino)styryl)phenyl)-
9H-carbazol-9-yl)thiophen-2-yl)benzo[c][1,2,5]thiadiazol-4-yl)thio-
phen-2-yl)-2-cyanoacrylic
acid
(H11). Piperidine
(51
mL,
0.51 mmol) was added to a mixture of 10 (200 mg, 0.17 mmol) and
cyanoacetic acid (43 mg, 0.51 mmol) in acetonitrile (20 mL) and
THF (20 mL). The mixture was refluxed overnight and then cooled
to room temperature. The mixture was extracted with MC and
water, and the organic phase was dried over sodium sulfate. The
solvent was evaporated to give a dark brown solid (98 mg, 46%),
which was purified by silica gel chromatography (eluent; MC/
MeOH/triethylamine (TEA)¼10:1:0.1). Mp 208e211 ꢂC; 1H NMR
Acknowledgements
(300 MHz, DMSO-d6):
d (ppm) 9.36 (s, 1H), 8.82 (s, 1H), 8.38e8.29
This work was supported by the National Research Foundation
of Korea (NRF) grant funded by the Korea government (MSIP)
for the Center for Next Generation Dye-sensitized Solar Cells
(No. 2013004800), and by a grant from the New & Renewable
Energy Technology Development Program of the KETEP (No.
20113020010070), funded by the Ministry of Knowledge Economy.
(m, 4H), 7.94e7.92 (m, 2H), 7.89e7.86 (d, J¼8.5 Hz, 5H), 7.73e7.67
(m, 6H), 7.57e7.55 (d, J¼7.9 Hz, 3H), 7.36e7.23 (m, 14H), 7.17e7.04
(m, 13H), 6.99e6.96 (d, J¼8.1 Hz, 5H); 13C NMR (75 MHz, DMSO-
d6):
d (ppm) 150.8, 147.5, 147.4, 132.1, 130.1, 128.2, 127.4, 124.7,
123.8; HRMS, m/z: calcd for C82H54N6O2S3: 1250.3470, found:
1250.3466.
4.2.14. 3-(5-(7-(5-(4-(3,6-Bis(4-(4-(diphenylamino)styryl)phenyl)-
9H-carbazol-9-yl)phenyl)thiophen-2-yl)benzo[c][1,2,5]thiadiazol-4-
yl)thiophen-2-yl)-2-cyanoacrylic acid (H12). This compound was
prepared according to the same synthetic procedure as H11, us-
ing 11 instead of 10. The product was obtained as a dark red solid
(55 mg, 48%). Mp 317e319 ꢂC; 1H NMR (300 MHz, CDCl3):
References and notes
€
€
€
€
d
(ppm) 8.76 (s, 2H), 8.19e8.22 (m, 3H), 8.08e8.11 (m, 3H),
7.83e7.85 (m, 4H), 7.69e7.71 (d, J¼7.8 Hz, 4H), 7.53e7.56 (m, 6H),
€
7.30e7.35 (m, 10H), 7.21e7.25 (m, 4H), 6.95e7.09 (m, 20H); 13C
€
NMR (150 MHz, CDCl3):
d (ppm) 147.6, 135.7, 129.3, 127.4, 124.4,
€
122.9; HRMS, m/z: calcd for C88H58N6O2S3: 1326.3785, found:
1326.3783.
€
4.2.15. 3-(5-(7-(5-(4-(3,6-Bis(4-(4-(diphenylamino)styryl)phenyl)-
9H-carbazol-9-yl)phenyl)-3-hexylthiophen-2-yl)benzo[c][1,2,5]thia-
diazol-4-yl)-4-hexylthiophen-2-yl)-2-cyanoacrylic acid (H13). This
€